Blood Cancer Talks

In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. 

Here are the key articles discussed:

1.      Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/
 
2.     Mayo 2004 staging:  https://pubmed.ncbi.nlm.nih.gov/15365071/
 
3.     Mayo 2012 staging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
 
4.     Renal staging: https://pubmed.ncbi.nlm.nih.gov/25115890/
 
5.     Hematologic and cardiac response criteria in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/23091105/
 
6.     ANDROMEDA Trial: Dara-VCD vs VCD in newly diagnosed AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34192431/
 
7.      How I Treat AL Amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34517412/
 
8.     Venetoclax in AL amyloidosis (largest retrospective study till date): 
https://pubmed.ncbi.nlm.nih.gov/33431806/

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk